E. Maria Lopez - Director, Nonclinical/CMC Regulatory Writing - Synchrogenix, a Certara company | LinkedIn
![CPhA on Twitter: "Dr. Maria Lopez is a pharmacist and small business owner (Mission Wellness Pharmacy) and she represents the #FaceOfPharmacy! Read Dr. Lopez's full profile and learn about other amazing CPhA CPhA on Twitter: "Dr. Maria Lopez is a pharmacist and small business owner (Mission Wellness Pharmacy) and she represents the #FaceOfPharmacy! Read Dr. Lopez's full profile and learn about other amazing CPhA](https://pbs.twimg.com/media/FYmxTFqXoAEnpng.jpg:large)
CPhA on Twitter: "Dr. Maria Lopez is a pharmacist and small business owner (Mission Wellness Pharmacy) and she represents the #FaceOfPharmacy! Read Dr. Lopez's full profile and learn about other amazing CPhA
![Maria BARRIGON | MD, PhD | Hospital Universitario Virgen del Rocío, Sevilla | HUVR | Psiquiatria | Research profile Maria BARRIGON | MD, PhD | Hospital Universitario Virgen del Rocío, Sevilla | HUVR | Psiquiatria | Research profile](https://i1.rgstatic.net/ii/profile.image/1060000201973760-1629735150065_Q512/Maria-Barrigon.jpg)
Maria BARRIGON | MD, PhD | Hospital Universitario Virgen del Rocío, Sevilla | HUVR | Psiquiatria | Research profile
![Jorge LOPEZ-CASTROMAN | M.D.,Ph.D. | Centre Hospitalier Régional Universitaire de Nîmes, Nîmes | Department of Psychiatry | Research profile Jorge LOPEZ-CASTROMAN | M.D.,Ph.D. | Centre Hospitalier Régional Universitaire de Nîmes, Nîmes | Department of Psychiatry | Research profile](https://i1.rgstatic.net/ii/profile.image/892650358071298-1589835838580_Q512/Jorge-Lopez-Castroman.jpg)
Jorge LOPEZ-CASTROMAN | M.D.,Ph.D. | Centre Hospitalier Régional Universitaire de Nîmes, Nîmes | Department of Psychiatry | Research profile
![Frontiers | Acceptability and satisfaction with emma, a smartphone application dedicated to suicide ecological assessment and prevention Frontiers | Acceptability and satisfaction with emma, a smartphone application dedicated to suicide ecological assessment and prevention](https://www.frontiersin.org/files/MyHome%20Article%20Library/952865/952865_Thumb_400.jpg)
Frontiers | Acceptability and satisfaction with emma, a smartphone application dedicated to suicide ecological assessment and prevention
![PDF) Metabolomics analysis of type 2 diabetes remission identifies 12 metabolites with predictive capacity: a CORDIOPREV clinical trial study PDF) Metabolomics analysis of type 2 diabetes remission identifies 12 metabolites with predictive capacity: a CORDIOPREV clinical trial study](https://i1.rgstatic.net/publication/364771255_Metabolomics_analysis_of_type_2_diabetes_remission_identifies_12_metabolites_with_predictive_capacity_a_CORDIOPREV_clinical_trial_study/links/635a481f8d4484154a3c06ef/largepreview.png)
PDF) Metabolomics analysis of type 2 diabetes remission identifies 12 metabolites with predictive capacity: a CORDIOPREV clinical trial study
![Kristen ECKSTRAND | Professor (Assistant) | MD, PhD | University of Pittsburgh, PA | Pitt | Department of Psychiatry | Research profile Kristen ECKSTRAND | Professor (Assistant) | MD, PhD | University of Pittsburgh, PA | Pitt | Department of Psychiatry | Research profile](https://i1.rgstatic.net/ii/profile.image/909572864757769-1593870478955_Q512/Kristen-Eckstrand.jpg)
Kristen ECKSTRAND | Professor (Assistant) | MD, PhD | University of Pittsburgh, PA | Pitt | Department of Psychiatry | Research profile
![Cancers | Free Full-Text | Toxicity of Asciminib in Real Clinical Practice: Analysis of Side Effects and Cross-Toxicity with Tyrosine Kinase Inhibitors Cancers | Free Full-Text | Toxicity of Asciminib in Real Clinical Practice: Analysis of Side Effects and Cross-Toxicity with Tyrosine Kinase Inhibitors](https://www.mdpi.com/cancers/cancers-15-01045/article_deploy/html/images/cancers-15-01045-g001.png)
Cancers | Free Full-Text | Toxicity of Asciminib in Real Clinical Practice: Analysis of Side Effects and Cross-Toxicity with Tyrosine Kinase Inhibitors
![Cancers | Free Full-Text | First-Line Treatment of Metastatic Clear Cell Renal Cell Carcinoma: What Are the Most Appropriate Combination Therapies? Cancers | Free Full-Text | First-Line Treatment of Metastatic Clear Cell Renal Cell Carcinoma: What Are the Most Appropriate Combination Therapies?](https://pub.mdpi-res.com/cancers/cancers-13-05548/article_deploy/html/images/cancers-13-05548-g001.png?1636104056)
Cancers | Free Full-Text | First-Line Treatment of Metastatic Clear Cell Renal Cell Carcinoma: What Are the Most Appropriate Combination Therapies?
E. Maria Lopez - Director, Nonclinical/CMC Regulatory Writing - Synchrogenix, a Certara company | LinkedIn
![Frontiers | High-Grade Glioma Treatment Response Monitoring Biomarkers: A Position Statement on the Evidence Supporting the Use of Advanced MRI Techniques in the Clinic, and the Latest Bench-to-Bedside Developments. Part 1: Perfusion Frontiers | High-Grade Glioma Treatment Response Monitoring Biomarkers: A Position Statement on the Evidence Supporting the Use of Advanced MRI Techniques in the Clinic, and the Latest Bench-to-Bedside Developments. Part 1: Perfusion](https://www.frontiersin.org/files/Articles/810263/fonc-12-810263-HTML-r5/image_m/fonc-12-810263-g001.jpg)